10-Q: Twinlab Faces Deepening Financial Woes, Debt Defaults

Twinlab Consolidated Holdings reports significant revenue decline, ongoing losses, and critical debt defaults, raising substantial doubt about its ability to continue as a going concern.

Summary

• Net sales from continuing operations decreased by 37% to $2.32 million for the three months ended September 30, 2024, compared to $3.68 million in the prior year.
• Gross profit from continuing operations fell by 52% to $0.64 million for the three months ended September 30, 2024, from $1.33 million in the same period last year.
• The company reported a net loss from continuing operations of $2.71 million for the three months ended September 30, 2024, an increase from a $2.35 million loss in the prior year.
• Total net loss for the three months ended September 30, 2024, was $2.68 million, an improvement from a $5.36 million loss in the prior year, primarily due to the cessation of discontinued operations.
• For the nine months ended September 30, 2024, net sales decreased by 22% to $8.21 million, and gross profit decreased by 32% to $2.71 million.
• The accumulated deficit increased to $376.49 million as of September 30, 2024.
• A working capital deficiency of $146.56 million was reported as of September 30, 2024.
• Cash on hand was critically low at $14 thousand as of September 30, 2024.
• The company is in default on multiple related-party notes payable totaling $76.07 million, which matured on October 22, 2021.
• Twinlab is also in default for non-compliance with the EBITDA-related financial covenant of its debt agreement with MidCap Funding X Trust, with $2.04 million due as of September 30, 2024.
• Discontinued operations (NutraScience Labs) generated a net income of $28 thousand for the three months ended September 30, 2024, a significant improvement from a $3.01 million loss in the prior year, following the abandonment of operations in July 2023.

Sentiment

Score: 2

Explanation: The sentiment is overwhelmingly negative due to significant declines in core business revenue and gross profit, persistent operating losses, a severe working capital deficiency, critically low cash reserves, and multiple debt defaults. The explicit 'going concern' warning and material weakness in internal controls further underscore the company's precarious financial position, despite some improvement from discontinued operations.

Positives

• The net income from discontinued operations significantly improved to $28 thousand for the three months ended September 30, 2024, compared to a $3.01 million loss in the prior year, contributing to a reduced total net loss.
• Total net loss decreased by 50% to $2.68 million for the three months ended September 30, 2024, compared to $5.36 million in the same period last year.
• Selling expenses decreased by 63% for both the three and nine-month periods ended September 30, 2024, due to reductions in digital advertising and general marketing costs.
• Interest expense, net, decreased by 7% and 8% for the three and nine-month periods, respectively, primarily due to a decrease in the cost of lending and associated interest fees.
• Net cash provided by operating activities was positive at $0.63 million for the nine months ended September 30, 2024.

Negatives

• Net sales from continuing operations decreased significantly by 37% for the three months and 22% for the nine months ended September 30, 2024, primarily due to supply chain issues on top-selling, high-margin products.
• Gross profit from continuing operations declined by 52% for the three months and 32% for the nine months ended September 30, 2024, attributed to supply chain issues and decreased demand from major retailers.
• Loss from operations increased by 269% for the three months ended September 30, 2024, reaching $0.75 million.
• The company has an accumulated deficit of $376.49 million and a working capital deficiency of $146.56 million as of September 30, 2024.
• Cash on hand is extremely low at $14 thousand, indicating severe liquidity constraints.
• All related-party notes payable to Little Harbor, Great Harbor Capital, LLC, and Golisano Holdings LLC, totaling $76.07 million, are currently in default.
• The company is in default of the EBITDA-related financial covenant of its Senior Credit Facility with MidCap Funding X Trust.
• A material weakness in internal controls over financial reporting exists due to a lack of appropriate staffing in accounting and information technology departments, limiting the ability to close books timely and accurately.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to historical operating losses, significant interest expense, a large accumulated deficit, and a working capital deficiency.
• Inability to raise additional capital through debt, equity, or asset sales on acceptable terms or at all, which could force the company to delay, limit, reduce, or terminate business efforts or file for bankruptcy.
• Default on multiple related-party debt agreements (Little Harbor, Great Harbor Capital, LLC, and Golisano Holdings LLC) and the MidCap Senior Credit Facility's financial covenants, which could lead to lenders exercising remedies.
• Significant customer concentration risk, with the top three customers accounting for 50% of sales for the three months and 54% for the nine months ended September 30, 2024.
• Ongoing supply chain disruptions impacting the availability of top-selling, high-margin products, leading to decreased sales and gross profit.
• Material weakness in internal controls over financial reporting due to insufficient staffing in accounting and IT, which could lead to financial statement errors or failure to meet reporting obligations.
• Potential dilution of existing stockholders' ownership interests if additional capital is raised through equity or convertible debt securities.
• Debt financing, if obtained, may impose restrictive covenants limiting the company's operational flexibility.

Future Outlook

Management is focused on growing core business and brands, emphasizing major customers and key products, reducing manufacturing and operating costs, and negotiating lower prices from major suppliers. The company anticipates needing to raise additional capital through debt, equity, or asset sales during the current year, but cannot guarantee funding availability on acceptable terms. They also anticipate extending maturity dates and payment deferrals with related-party lenders, though no assurance is given. The company is assessing the impact of new segment reporting disclosure requirements (ASU 2023-07) effective for fiscal years beginning after December 15, 2023.

Management Comments

• Management is addressing operating issues through focusing on growing the core business and brands, continuing emphasis on major customers and key products, and continuing to negotiate lower prices from major suppliers.
• We will need to raise additional capital through debt, equity or the sale of assets during the current year.
• There can be no assurance that sources of funding will be available when needed on acceptable terms or at all.
• If we cannot obtain additional funding when required, the Company may sell certain assets, enter into collaborations, strategic alliances, merger and acquisition activities, and licensing agreements, negotiate with its principal lenders, wind-up operations of other subsidiaries, or file for bankruptcy protection.
• We continue to anticipate extending the maturity dates and related payment deferrals with the lenders, but we cannot guarantee that such extensions and payment deferrals will be successfully obtained.
• The Company has a lack of appropriate staffing in our accounting and information technology departments to address the Company's ability to continue to close the books both timely and accurately and to meet internal control processes. The Company's ability to address this material weakness is limited due to the lack of financing.

Industry Context

The filing indicates that the company operates in the nutritional supplements and natural products industry, selling through various retail channels. The reported decline in sales and gross profit, partly attributed to supply chain issues and decreased demand from major retailers, suggests the company is struggling within a competitive market, potentially facing broader economic pressures or specific challenges in its product categories. The cessation of the NutraScience Labs private label operations reflects a strategic shift or a failure to compete effectively in that segment.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• The company is not aware of any legal proceedings that could have a material impact on its financial condition, results of operations, or cash flows as of the date of this Quarterly Report on Form 10-Q.

Related Party Transactions

• Little Harbor, LLC (owned by Chairman David L. Van Andel) holds $8.04 million in notes payable, which are currently in default.
• Great Harbor Capital, LLC (owned by Chairman David L. Van Andel) holds $28.50 million in notes payable, which are currently in default.
• Golisano Holdings LLC (principal B. Thomas Golisano, a former director) holds $39.54 million in notes payable, which are currently in default.
• Macatawa Bank (former director Mark Bugge, and Mr. Van Andel has an indirect interest in a trust holding >10% ownership in Macatawa) held a Term Loan of $14.88 million, which was settled by collateral surrender on November 30, 2024.
• As of December 30, 2024, all debts and interest due to Little Harbor and Great Harbor Capital, LLC, including one-half of the Macatawa debt, were assigned to Akretive, LLC.
• As of April 22, 2025, all debts and interest due to Golisano Holdings LLC, including one-half of the Macatawa debt, were assigned to Akretive, LLC.

Stakeholder Impact

• Shareholders face significant dilution risk if the company raises capital through equity offerings, and potential loss of investment due to the 'going concern' doubt and severe financial distress.
• Creditors (especially related parties) are impacted by the company's defaults on substantial debt obligations, though some debts have been assigned to Akretive, LLC.
• Employees may face job insecurity or increased workload due to the company's financial difficulties and stated lack of appropriate staffing in key departments.
• Customers and suppliers may experience disruptions due to ongoing supply chain issues and the company's liquidity constraints affecting product availability and payment terms.

Next Steps

• Focus on growing the core business and brands.
• Continue emphasis on major customers and key products.
• Reduce manufacturing and operating costs.
• Continue to negotiate lower prices from major suppliers.
• Raise additional capital through debt, equity, or the sale of assets.
• Seek extensions for maturity dates and payment deferrals with related-party lenders.
• Remediate material weakness in internal controls by hiring, training, and retaining appropriate staff in accounting, finance, and IT departments.
• Assess the impact of the new ASU 2023-07 on segment reporting for fiscal years beginning after December 15, 2023.

Key Dates

Recommendation

The company faces severe financial distress, evidenced by a 'going concern' warning, substantial accumulated deficit, critical working capital deficiency, and critically low cash reserves. Core business revenue and gross profit are declining significantly, and the company is in default on multiple debt agreements, including related-party notes and a financial covenant with its senior lender. A material weakness in internal controls further exacerbates operational risk. While the total net loss decreased, this was primarily due to the cessation of a loss-making discontinued operation, masking the deteriorating performance of continuing operations. The high level of uncertainty regarding future funding and the company's ability to resolve its defaults and operational weaknesses makes it a high-risk investment with significant downside potential.

Keywords

Nutritional Supplements, SEC Filing, 10-Q, Twinlab, Financial Performance, Going Concern, Debt Default, Working Capital Deficiency, Liquidity, Supply Chain, Internal Controls, Related Party Debt, Health and Natural Food, Vitamins, Minerals, Sports Nutrition